Patents by Inventor Hakan BLADH

Hakan BLADH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS
    Publication number: 20090286835
    Abstract: The present invention provides compounds of formula (I) wherein n, p, R1, R2, X1, X2, X3, X4, X5, R3a, R3b, R4, R5 and R6 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: October 3, 2008
    Publication date: November 19, 2009
    Applicant: AstraZeneca AB
    Inventors: Hakan BLADH, Frank Burkamp, Balint Gabos, Peter Hansen, Svetlana Ivanova, Karolina Lawitz
  • Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases
    Publication number: 20090124607
    Abstract: Compounds of formula (I): or a pharmaceutically acceptable salt thereof; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
    Type: Application
    Filed: October 18, 2006
    Publication date: May 14, 2009
    Inventors: Hakan Bladh, Jan Dahmen, Thomas Hansson, Krister Henriksson, Matti Lepisto, Stinabritt Nilsson
  • Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
    Publication number: 20090093485
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
    Type: Application
    Filed: October 26, 2005
    Publication date: April 9, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Hakan Bladh, Krister Henriksson, Vijaykumar Hulikal, Matti Lepisto
  • Use of Unsaturated Quionoline or Naphtalene Derivatives as Medicaments
    Publication number: 20090036484
    Abstract: A compound of formula (I): (I), or a pharmaceutically acceptable salt thereof; for use as a medicament (for example modulating the glucocorticoid receptor in a warm blooded animal), and pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: October 26, 2005
    Publication date: February 5, 2009
    Applicant: AstraZeneca AB
    Inventor: Hakan Bladh
  • Quinoline derivatives as neutrophil elastase inhibitors and their use
    Publication number: 20070010551
    Abstract: There are provided novel compounds of formula (I) wherein R1, R3, R4, R5, G1, G2, L and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of neutrophil elastase.
    Type: Application
    Filed: August 25, 2004
    Publication date: January 11, 2007
    Inventors: Hakan Bladh, Joakim Larsson
  • Quinoxaline derivatives as neutrophil elastase inhibitors and their use
    Publication number: 20060270666
    Abstract: There are provided novel compounds of formula (I) wherein R1, R4, R5, G1, G2, L and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of neutrophil elastase.
    Type: Application
    Filed: August 25, 2004
    Publication date: November 30, 2006
    Inventors: Hakan Bladh, Joakim Larsson
  • 2-Pyridone derivatives as inhibitors of neutrophile elastase
    Publication number: 20060035938
    Abstract: There are provided novel compounds of formula (I) wherein R1?, R4?. R5?, G1?, G2?, X, L, Y1?, Y2? and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors or neutrophil elastase.
    Type: Application
    Filed: November 11, 2003
    Publication date: February 16, 2006
    Inventors: Hakan Bladh, Tomas Klingstedt, Joakim Larsson, Karolina Lawitz, Matti Lepisto, Hans Lonn, Grigorios Nikitidis
  • Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
    Publication number: 20040132724
    Abstract: Compounds of formula (I) are modulators of STAT6 signal pathway activity, and can be used in the treatment of atopic dermatitis, urticaria, allergic asthma, allergic rhinitis, a food allergy, allergic conjunctivitis, hayfever, bullous pemphigoid, industrial sensitization, chronic rejection of transplants or COPD.
    Type: Application
    Filed: September 29, 2003
    Publication date: July 8, 2004
    Inventors: Hakan Bladh, Thomas Hansson, Grigorios Nikitidis, Carita Norden, Lars Pettersson, Mikael Varga